Valeant Pharmaceuticals International Inc.’s hostile bid for Cephalon Inc. is so low that Valeant could raise the offer by 15 percent and still pay less than any drug takeover in history."
Source : Google Reader
Thursday, 31 March 2011
Google Reader (1000+)
"Valeant Bid for Cephalon Still Lowest With 15% Boost: Real M&A
Valeant Pharmaceuticals International Inc.’s hostile bid for Cephalon Inc. is so low that Valeant could raise the offer by 15 percent and still pay less than any drug takeover in history."
Valeant Pharmaceuticals International Inc.’s hostile bid for Cephalon Inc. is so low that Valeant could raise the offer by 15 percent and still pay less than any drug takeover in history."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment